Share

Ebola

Read the Press Release

Johnson & Johnson Announces New U.S. Support for Ebola Vaccine Development

Johnson & Johnson Announces New U.S. Support for Ebola Vaccine Development

Two Milestones for Ebola Vaccine Program

Developing the Tools to Stop Ebola

New Ebola Study Focused on Helping Halt Future Outbreaks

Ebola Virus News

Innovation

March 14, 2017

Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study

Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study

Alex Gorsky - Ebola

Global Public Health

September 29, 2016

Photo Gallery: Staying at Zero in Sierra Leone

Photo Gallery: Staying at Zero in Sierra Leone

Global Public Health

October 26, 2016

Video: The Business Debate - Johan Van Hoof on Johnson & Johnson's Commitment to Combat Ebola

Video: The Business Debate - Johan Van Hoof on Johnson & Johnson's Commitment to Combat Ebola

Innovation

March 15, 2016

The Race to Create an Ebola Vaccine

The Race to Create an Ebola Vaccine

Start of Clinical Trial in Sierra Leone

Start of Clinical Trial in Sierra Leone

Corporate

January 16, 2015

Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative

Johnson & Johnson Announces Formation of Ebola Vaccine Development Consortia, Gains Funding from Innovative Medicines Initiative

Media Coverage

Fox News: "A One-Two Punch Against Ebola"

Fox News: "A One-Two Punch Against Ebola"

Reuters: Two-Part Ebola Vaccine Offers Long-Lasting Protection

Reuters: Two-Part Ebola Vaccine Offers Long-Lasting Protection

STAT: J&J Begins Testing Multivalent Ebola Vaccine

STAT: J&J Begins Testing Multivalent Ebola Vaccine

Bloomberg: Ebola Vaccine Has Promise

Bloomberg: Ebola Vaccine Has Promise

More From Johnson & Johnson

A graphic of a close-up view of bladder cancer

Innovation

From Aha! Moment to FDA Approval: The Fascinating Story Behind a New Treatment for Bladder Cancer

From Aha! Moment to FDA Approval: The Fascinating Story Behind a New Treatment for Bladder Cancer

We retrace the 22-year journey it took to bring a potentially life-changing treatment for an aggressive form of the disease to patients who may benefit most.

Latest News

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

How Johnson & Johnson Is Helping Tackle a Devastating Tropical Disease That Impacts Kids

A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.

Tuberculosis survivors Manasi Khade and Gerry Elsdon

Personal Stories

"We Weren't Supposed to Get Tuberculosis": Meet Two Surprising Survivors Who Could Be You

"We Weren't Supposed to Get Tuberculosis": Meet Two Surprising Survivors Who Could Be You

A 20-something photographer. A famous TV personality. They share one thing in common that you'd never expect—both have triumphed over tuberculosis. For World TB Day, we share their inspiring stories.